Tuesday, Dec. 18
George Bakris, MDProfessor of MedicineUniversity of Chicago Medicine
“Changing Trajectory of Diabetic Kidney Disease”
For more than three decades, Dr. Bakris has worked on the front lines of kidney disease, hypertension and diabetes research, and he has made crucial discoveries that have had a lasting effect on diabetes and hypertension therapy. Bakris specializes in kidney research, but has also crossed over into overlapping therapeutic areas like CVD and diabetes management.
Tuesday, Dec. 11
Javed Butler, MD, MPH, MBAProfessor, Chair of Medicine
“Department of Medicine Faculty Meeting”
Tuesday, Dec. 4
Kenneth Vick, MDProfessor, General Surgery
“Bariatric Surgery: What should the Internist know?”
Tuesday, Nov. 27
Robert Mentz, MDAssistant Professor of MedicineDirector, Duke University Cooperative Cardiovascular SocietyAdvanced Heart Failure and Cardiac TransplantationDuke University Medicine Center | Duke Clinical Research Institute“Pragmatic Trials: Lessons Learned and Future Directions”
Dr. Robert Mentz is a cardiologist in Durham, North Carolina and is affiliated with Duke University Hospital. He received his medical degree from Emory University School of Medicine and has been in practice between 6-10 years. He is one of 111 doctors at Duke University Hospital who specialize in Cardiology.
Tuesday, Nov. 13
Clinical Quality Improvement Conference
Tuesday, Nov. 6
Daniel Dressler, MD, MSc Professor of Medicine Director“Updates in Hospital Medicine”
Daniel D. Dressler, MD, MSc, SFHM, FACP is Professor of Medicine, Hospital Medicine Associate Division Director for Education, Director of Internal Medicine Teaching Services at Emory University Hospital, Associate Program Director for the J. Willis Hurst Internal Medicine Residency Program, and Medical Student Semmelweis Society Advisor at Emory University’s School of Medicine in Atlanta, GA. He was founding Director of Hospital Medicine at Emory University Hospital. He completed his undergraduate training at Duke University in Physics, and his medical training at Emory University School of Medicine. He completed his Internal Medicine residency at Emory University, followed by a fellowship in Hospital Medicine and a Master of Science in Clinical Research. He is board certified in internal medicine with Focused Practice certification in Hospital Medicine.
Tuesday, Oct. 30
Tuesday, Oct. 23
Robert Munford, MD“Sepsis 2018: New Ideas, New Therapies?”
Dr. Munford received his B.A. in history from Vanderbilt University and the M.A. in animal physiology from Oxford University before attending Harvard Medical School. After training in internal medicine at Parkland Memorial Hospital, Dallas, Texas, he served as an Epidemic Intelligence Service officer at the Centers for Disease Control and Prevention, did postdoctoral research at the Rockefeller University, and completed an infectious disease fellowship at the Massachusetts General Hospital. He worked for many years as a physician-scientist at the University of Texas Southwestern Medical School in Dallas before moving to the National Institutes of Health in 2009. His interest in bacterial lipopolysaccharides began when he investigated an outbreak of meningococcal disease in São Paulo, Brazil, in 1972. His lab's major research goal has been to understand how animals inactivate these highly stimulatory molecules.
Tuesday, Oct. 16
Steve Marso, MDMedical Director, Midwest Heart & VascularInstitute, Kansas City
Dr. Marso is the Medical Director for Cardiovascular Services for HCA Midwest Health in Kansas City Missouri. Prior to this, he was Professor of Medicine and Medical Director of Interventional Cardiology at the University of Texas Southwestern, Dallas Texas. Dr. Marso began his career as a Clinical Scholar and Cardiologist at the Mid America Heart Institute in Kansas City. He is a practicing Interventional Cardiologist and clinical researcher. Dr. Marso’s research interests include designing and overseeing clinical trials that evaluate the cardiovascular safety and efficacy of emerging therapies to treat diabetes and obesity. He has been involved in the trial leadership of several pivotal large-scale cardiovascular outcome trials. Dr. Marso also has a research interest in evaluating the outcomes following PCI using large national databases and an ongoing interest in quality improvement. Dr. Marso earned his medical degree at the University of Kansas and trained in Internal Medicine at the University of Virginia. He went on to complete his cardiovascular Fellowship in Cardiovascular Medicine at the Cleveland Clinic Foundation. Professor Marso has published over 180 peer-reviewed manuscripts, edited four textbooks, mentored over 30 Interventional Cardiology fellows and is a frequent invited lecturer on the topics of PCI and diabetes and cardiovascular disease.
Tuesday, Oct. 9
William C. Little, MD, Memorial LectureJagat Narula, MD, PhD, MACCProfessor of Medicine (Cardiology)Chief of CardiologySt. Luke’s Hospital of Mt. Sinai
“Can We Eliminate Coronary Disease in Our Lifetime?”
Professor Jagat Narula, MD, PhD, MACC, is a Philip J. and Harriet L. Goodhart Chair of Cardiology at the Zena & Michael A. Wiener Cardiovascular Institute of the Icahn School of Medicine at Mount Sinai, Chief of the Division of Cardiology of St. Luke’s Hospital of Mt. Sinai, Director of Cardiovascular Imaging Program for the Mt. Sinai Health System, and Associate Dean of the Arnhold Institute for Global Health at Mt. Sinai.
Tuesday, Sept. 25
William Hillegass, MD-MPH, PhDAssociate Professor of Cardiovascular MedicineAssistant Professor of BiostatisticsUniversity of Alabama
“Biostatistics, Data Science, & Cardiovascular Disease”
Dr. Hillegass is an Associate Professor of Medicine in the Cardiovascular Division and holds a secondary appointment as an Assistant Professor of Biostatistics. In addition to general and invasive cardiovascular practice, Dr. Hillegass is a clinical investigator. Using research methods ranging from prospective randomized trials to secondary data-analyses, his applied research includes antithrombotic therapies, acute coronary syndromes, peripheral vascular diseases, cardiovascular diseases in diabetics, and interventional therapies. His basic statistical methods research concerns indirect treatment comparison methods. He has focused on quantitative methods to verify the assumptions and validity of indirect treatment comparison methods such as network meta-analysis. He has developed methods to improve the robustness of indirect treatment effect estimators. His additional methodological areas of interest and research include individual patient data meta-analysis, retrospective harmonization of covariates and endpoints across studies & databases, adaptive clinical trial designs, simulated clinical trials, bioinformatics for precision medicine, and cost-effectiveness analyses. Dr. Hillegass studied molecular genetics and econometrics as an undergraduate at Yale. Medicine and clinical research design & application at Harvard Medical School, Harvard School Public Health, and Brigham and Women's Hospital. He trained in cardiovascular diseases and cardiovascular research at Duke University Medical Center and the Duke Clinical Research Institute. His PhD training in biostatistics was at the University of Alabama at Birmingham.
Tuesday, Sept. 18
Richard M. Wardrop III, MD, PhDAssociate Professor of Pediatrics and MedicineUniversity of North Carolina
“Back to the Future: Reimaging GME Funding to Meet the Quadruple Aim”
Tuesday, Sept. 11
Javed Butler, MD, MPH, MBARichard Summers, MDAdolfo Correa, MD, PhDGailen Marshall, MD, PhD
“Update on the Jackson Heart Study”
Tuesday, Sept. 4
Jesse Roman, MDProfessor, Department of MedicineUniversity of Louisville, Kentucky
“My Doctor, My Scientist”
Dr. Jesse Roman is Ludwig Kind Professor of Medicine and Pharmacology & Experimental Therapeutics; Enterprise Division Chief for Pulmonary, Allergy and Critical Care Medicine; and Chief Executive Officer of the Jane & Leonard Korman Respiratory Institute – Jefferson Health and National Jewish Health in Philadelphia, Pennsylvania. Dr. Roman received his MD from the University Of Puerto Rico School Of Medicine in 1983. After undergoing training in Internal Medicine at the San Juan VA Medical Center in Puerto Rico, he joined the Pulmonary & Critical Care Medicine Fellowship Program at Washington University School of Medicine, St. Louis, Missouri. In 1991, Dr. Roman joined the faculty at Emory University where he became Professor and Division Chief (2002), co-founder and Director for Research of the Emory Interstitial Lung Diseases Program (2003), and AVP and Founding Director of the Emory Center for Respiratory Health (2007). In 2009, Dr. Roman became Professor, Distinguished University Scholar, and Chairman of the Department of Medicine at the University of Louisville, Kentucky. Dr. Roman remains clinically active in interstitial lung disorders and has written extensively in the areas of lung tissue remodeling and inflammation, and on the role of extracellular matrices in the control of cellular functions. He is the current Editor-In-Chief of the American Journal of the Medical Sciences and serves as past chair of the RCMB Assembly and the Scientific Advisory Committee of the American Thoracic Society, and recently served as chair of its Health Equality Committee. Dr. Roman also serves on the Medical Advisory Committee of the Pulmonary Fibrosis Foundation.
Tuesday, Aug. 21
Raman Palabindala, MDAssociate Professor, Hospitalist Division
“Altruism and Business Clinical Documentation Excellence ‘ABCDE’ Part II. It is not all about money.”
Tuesday, Aug. 14
Manoocher Soleimani, MDJames Heady Professor of MedicineAssociate Chair for Research, Department of MedicineUniversity of Cincinnati
“New Diuretic Targets: Time to Re-evaluate Old Concepts”